Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSorafenib as second‐line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma.AuthorsTomonari, Tetsu; Sato, Yasushi; Tanaka, Hironori; Tanaka, Takahiro; Taniguchi, Tatsuya; Sogabe, Msasahiro; Okamoto, Koichi; Miyamoto, Hiroshi; Muguruma, Naoki; Takayama, TetsujiPublicationJGH Open, 2020, Vol 4, Issue 6, p1135ISSN2397-9070Publication typeArticleDOI10.1002/jgh3.12408